CommentaryComment on: “Follow-up study of hyperimmune goat serum (AIMSPRO®) for amyotrophic lateral sclerosis”
References (14)
Designing clinical trials in amyotrophic lateral sclerosis
Phys Med Rehabil Clin N Am
(2008)- et al.
Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration
Chest
(1993) - et al.
BiPAP improves survival and rate of pulmonary function decline in patients with ALS
J Neurol Sci
(1999) - et al.
Hyperimmune Goat Serum for amyotrophic lateral sclerosis
J Clin Neurosci
(2006) - et al.
Hyperimmune Goat Serum (Aimspro): Hope or hype?
J Clin Neurosci
(2006) - et al.
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group
N Engl J Med
(1994) Issues in amyotrophic lateral sclerosis clinical trial design
Adv Neurol
(1995)
There are more references available in the full text version of this article.
Cited by (2)
Reply to "Comment on: 'Follow-up study of hyperimmune goat serum (AIMSPRO®) for amyotrophic lateral sclerosis'"
2010, Journal of Clinical NeuroscienceALSUntangled No. 7: Investigating hyperimmune goat serum (Aimspro) for ALS
2010, Amyotrophic Lateral Sclerosis
Crown copyright © 2009 Published by Elsevier Ltd. All rights reserved.